Hepatocellular carcinoma treated with sorafenib: authors' reply

被引：0
|
作者：
Peck-Radosavljevic, M. [1 ]
Pinter, M. [1 ]
Sieghart, W. [1 ]
机构：
[1] Med Univ Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 34卷 / 11-12期
关键词：
D O I：
10.1111/j.1365-2036.2011.04889.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1348 / 1349
页数：2
相关论文
共 50 条
  • [1] Hepatocellular carcinoma treated with sorafenib
    Han, G.
    Zhao, Y.
    Qi, X.
    Fan, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) : 1347 - 1348
  • [2] Sorafenib in Advanced Hepatocellular Carcinoma Reply
    Llovet, Josep M.
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2498 - 2499
  • [3] Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
    Ko, Yi-Ling
    Takata, Kazuhide
    Tanaka, Takashi
    Ohishi, Jun
    Takeshita, Morishige
    Yamauchi, Ryo
    Fukuda, Hiromi
    Miyayama, Takashi
    Uchida, Yotaro
    Yokoyama, Keiji
    Morihara, Daisuke
    Takeyama, Yasuaki
    Shakado, Satoshi
    Sakisaka, Shotaro
    Hirai, Fumihito
    CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (01) : 226 - 233
  • [4] The prognostic markers in hepatocellular carcinoma treated with sorafenib
    Kawasaki, Takeshi
    Tokunaga, Takayuki
    Fujie, Satomi
    Yoshimaru, Yoko
    Watanabe, Takehisa
    Setoyama, Hiroko
    Tateyama, Masakuni
    Tanaka, Motohiko
    Sasaki, Yutaka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 419 - 419
  • [5] EBM and the diagnosis of hepatocellular carcinoma - Authors' reply
    Burroughs, AK
    Fung, KTT
    Li, FTW
    Raimondo, ML
    Maudgil, D
    Mancuso, A
    Tibballs, JM
    Watkinson, AA
    Patch, A
    BRITISH JOURNAL OF RADIOLOGY, 2005, 78 (928): : 371 - 372
  • [6] Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma"
    Bruix, Jordi
    Cheng, Ann Lii
    Llovet, Josep
    JOURNAL OF HEPATOLOGY, 2018, 68 (03) : 620 - 621
  • [7] Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply
    Cabibbo, G.
    Genco, C.
    Camma, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 862 - 863
  • [8] Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Pomej, Katharina
    Scheiner, Bernhard
    Park, Dabin
    Bauer, David
    Balcar, Lorenz
    Meischl, Tobias
    Mandorfer, Mattias
    Reiberger, Thomas
    Muller, Christian
    Trauner, Michael
    Pinter, Matthias
    CANCERS, 2020, 12 (10) : 1 - 14
  • [9] Remission of Psoriasis in a Patient with Hepatocellular Carcinoma Treated with Sorafenib
    Antoniou, Efstathios A.
    Koutsounas, Ioannis
    Damaskos, Christos
    Koutsounas, Sotiris
    IN VIVO, 2016, 30 (05): : 677 - 680
  • [10] Advanced hepatocellular carcinoma treated by a combination of sorafenib and radiotherapy
    Yang, Bi-Ling
    Yeh, Chun
    Hsu, Chung-Te
    Chang, Tien-Yu
    Wang, Chung-Yih
    ADVANCES IN DIGESTIVE MEDICINE, 2014, 1 (01) : 25 - 29
12345